Sign Up to like & get
recommendations!
0
Published in 2020 at "Journal of Clinical Neuroscience"
DOI: 10.1016/j.jocn.2020.09.054
Abstract: BACKGROUND Semaglutide, a glucagon-like peptide-1 (GLP-1) analogue with an extended half-life of approximately 1 week has being come into clinic trial to treat parkingson's disease but little is known about its effect to prevent against Alzheimer's…
read more here.
Keywords:
protection correlated;
inhibition;
mediated protection;
semaglutide protect ... See more keywords